SeekingAlpha · Aug 12, 2026
Organigram Global Inc. 2026 Q3 - Results - Earnings Call Presentation
2026-08-12. The following slide deck was published by Organigram Global Inc.
NASDAQ · OGI
Organigram Global Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$1.25
Up+$0.05 (+4.17%)
Updated Aug 22, 2026, 6:26 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 220.47M
- P/E ratio
- 38.94
- Dividend yield
- 0.00%
- 52-week range
- $0.85 – $2.24
- Volume
- 522.49K
- Avg. volume
- 625.6K
Price performance
OGI price history
1M range · 21 trading sessions · Daily adjusted prices
OGI closed at $1.25 after 21 trading sessions, up 33.73% for the selected period.
- Last close
- $1.25
- Period change
- +33.73%
- Period low
- $0.93
- Period high
- $1.29
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $1.21 | $1.265 | $1.20 | $1.25 | 522.49K |
| Aug 20, 2026 | $1.23 | $1.24 | $1.18 | $1.20 | 826.01K |
| Aug 19, 2026 | $1.21 | $1.25 | $1.21 | $1.24 | 547.18K |
| Aug 18, 2026 | $1.22 | $1.24 | $1.20 | $1.21 | 533.61K |
| Aug 17, 2026 | $1.22 | $1.26 | $1.20 | $1.225 | 785.76K |
| Aug 14, 2026 | $1.25 | $1.28 | $1.20 | $1.23 | 1.01M |
| Aug 13, 2026 | $1.29 | $1.32 | $1.25 | $1.26 | 979.65K |
| Aug 12, 2026 | $1.15 | $1.32 | $1.15 | $1.29 | 2.45M |
| Aug 11, 2026 | $1.20 | $1.24 | $1.12 | $1.23 | 23.87M |
| Aug 10, 2026 | $0.9825 | $1.05 | $0.9802 | $1.05 | 775.29K |
| Aug 7, 2026 | $0.9854 | $1.02 | $0.97 | $0.99 | 356.42K |
| Aug 6, 2026 | $0.98 | $0.9991 | $0.96 | $0.99 | 204.51K |
| Aug 5, 2026 | $0.99 | $0.99 | $0.9428 | $0.9741 | 175.18K |
| Aug 4, 2026 | $0.98 | $0.9928 | $0.95 | $0.9928 | 438.99K |
| Aug 3, 2026 | $0.9314 | $0.9699 | $0.9301 | $0.9644 | 131.81K |
| Jul 31, 2026 | $0.9638 | $0.9691 | $0.9201 | $0.9393 | 203.88K |
| Jul 30, 2026 | $0.93 | $0.97 | $0.9102 | $0.968 | 310.14K |
| Jul 29, 2026 | $0.93 | $0.9374 | $0.9053 | $0.93 | 179.53K |
| Jul 28, 2026 | $0.95 | $0.95 | $0.915 | $0.9487 | 108.62K |
| Jul 27, 2026 | $0.9227 | $0.9699 | $0.9227 | $0.9394 | 136.06K |
| Jul 24, 2026 | $0.91 | $0.9446 | $0.895 | $0.9347 | 198.04K |
Latest OGI news
The latest Smart Investors Daily articles mentioning OGI.
Stock researchCompany · Overview
OGI research
Overview
Company profile and research snapshot.
Company profile
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 12, 2026 | ATB CAPITAL MARKETS | Outperform | — |
| May 11, 2026 | ALLIANCE GLOBAL PARTNERS | Buy | — |
| May 11, 2026 | HAYWOOD SECURITIES INC. | Buy | — |
| May 11, 2026 | CANACCORD GENUITY | Buy | — |
| Feb 23, 2026 | ALLIANCE GLOBAL PARTNERS | Buy | — |
News briefing
No generated briefing is available yet.
Yahoo · Aug 12, 2026
Organigram Global Inc. Q3 2026 Earnings Call Summary
Moby summary of Organigram Global Inc.'s Q3 2026 earnings call
Yahoo · Aug 11, 2026
Organigram Global Inc (OGI) (Q3 2026) Earnings Call Highlights: Record Revenue and EBITDA ...
International expansion drives 49% revenue surge and record profitability, with full-year guidance raised above $350 million.
SeekingAlpha · Aug 11, 2026
Village Farms Is Undervalued As International Cannabis Revenue Hits Record Levels
Village Farms International's Q2 showed record international cannabis sales, facility expansion, cost cuts & a strong balance sheet. Read more about VFF stock.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
